author-photo

Hirofumi Hamada

Sapporo Medical University
Japanese Foundation for Cancer Research
University of Tokyo

360

Papers

20124

Citations

Citation Trend

Filter By

Papers (360) Sort By

Journal Conference Others

Datopotamab deruxtecan (Dato-DXd), a novel TROP2-directed antibody-drug conjugate, demonstrates potent antitumor activity by efficient drug delivery to tumor cells

2021 Molecular Cancer Therapeutics
Show All
- Source
- Cite
- Save
Citations (0)
Antibody screening system using an HSV-based probe to identify a novel target for receptor-retargeted oncolytic HSVs.

2021 Journal of Virology
Show All
- Source
- Cite
- Save
Citations (1)
Clarifying Institutional and Organizational Conditions Promoting Principals' Quality Leadership and Reform Design for Japan

2021
- Hirofumi Hamada
Show All
- Source
- Cite
- Save
Citations (0)
校長のリーダーシップ発揮を促進する制度的・組織的条件の解明と日本の改革デザイン（3） : 初任期小学校校長インタビュー調査の分析

2021
Show All
- Source
- Cite
- Save
Citations (0)
Interleukin-13 receptor α2 is a novel marker and potential therapeutic target for human melanoma

2019 Scientific Reports
Show All
- Source
- Cite
- Save
Citations (18)
Oncolytic Herpes Simplex Virus Vectors Fully Retargeted to Tumor- Associated Antigens

2018 Current Cancer Drug Targets
Show All
- Source
- Cite
- Save
Citations (13)
「指標化」「基準化」の動向と課題ガバナンス改革における教職の位置と「教員育成指標」をめぐる問題

2017
Show All
- Source
- Cite
- Save
Citations (0)
Syncytial Mutations Do not Impair the Specificity of Entry and Spread of a Glycoprotein D Receptor-Retargeted Herpes Simplex Virus

2016 Journal of Virology
Show All
- Source
- Cite
- Save
Citations (6)
Cell Surface Antibody Retention Influences In Vivo Antitumor Activity Mediated by Antibody-dependent Cellular Cytotoxicity

2016 Anticancer Research
Show All
- Source
- Cite
- Save
Citations (1)
Pr1E11, a novel anti-TROP-2 antibody isolated by adenovirus-based antibody screening, recognizes a unique epitope

2015 Biochemical and Biophysical Research Communications
Show All
- Source
- Cite
- Save
Citations (4)